Who's the new king of the drug launch hill? Hint: It's all in the Gilead family

Move over, Sovaldi--there's a new launch king in town. And luckily for Gilead ($GILD), it's another of its own. Harvoni has officially unseated its hep C predecessor, putting up sales figures and script numbers that beat Sovaldi's at this point in its launch. Report